-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
-
Summary
-
Bolt Biotherapeutics, Inc. quarterly/annual Depreciation history and growth rate from 2020 to 2024.
- Bolt Biotherapeutics, Inc. Depreciation for the quarter ending December 31, 2024 was $400K, a 20% decline year-over-year.
- Bolt Biotherapeutics, Inc. Depreciation for the twelve months ending December 31, 2024 was $1.8M, a 5.26% decline year-over-year.
- Bolt Biotherapeutics, Inc. annual Depreciation for 2024 was $1.8M, a 5.26% decline from 2023.
- Bolt Biotherapeutics, Inc. annual Depreciation for 2023 was $1.9M, a 11.8% increase from 2022.
- Bolt Biotherapeutics, Inc. annual Depreciation for 2022 was $1.7M, a 41.7% increase from 2021.
Depreciation, Trailing 12 Months (USD)
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)